These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 3285349
1. Mechanisms of hypopigmentation in human oculocutaneous albinism. King RA, Olds DP, Townsend D. Prog Clin Biol Res; 1988; 256():183-91. PubMed ID: 3285349 [Abstract] [Full Text] [Related]
3. Mutation analysis of the tyrosinase gene in oculocutaneous albinism. Camand O, Marchant D, Boutboul S, Péquignot M, Odent S, Dollfus H, Sutherland J, Levin A, Menasche M, Marsac C, Dufier JL, Heon E, Abitbol M. Hum Mutat; 2001 Apr; 17(4):352. PubMed ID: 11295837 [Abstract] [Full Text] [Related]
4. [Human oculocutaneous albinism. From clinical observation to molecular biology]. Aquaron R. Bull Soc Pathol Exot; 1993 Apr; 86(5):313-26. PubMed ID: 8124097 [Abstract] [Full Text] [Related]
5. Albinism and its implications with vision. Kirkwood BJ. Insight; 2009 Apr; 34(2):13-6. PubMed ID: 19534229 [Abstract] [Full Text] [Related]
6. [Normalization of melanin synthesis in the ocular pigment epithelium of albino ap toad embryos]. Khoperskaia OA. Dokl Akad Nauk SSSR; 1977 Apr; 236(4):998-100. PubMed ID: 923426 [No Abstract] [Full Text] [Related]
7. Oculocutaneous albinism type 1A: a case report. Karaman A. Dermatol Online J; 2008 Nov 15; 14(11):13. PubMed ID: 19094851 [Abstract] [Full Text] [Related]
8. [Hereditary anomalies of melanin metabolism (apropos of 5 cases)]. Geormăneanu M, Sanielevici-Marinov S, Mark E, Gârbacea G, Gherghina I. Pediatria (Bucur); 1972 Nov 15; 21(4):327-34. PubMed ID: 4661110 [No Abstract] [Full Text] [Related]
9. Hairbulb tyrosinase activity in oculocutaneous albinism: suggestions for pathway control and block location. King RA, Olds DP. Am J Med Genet; 1985 Jan 15; 20(1):49-55. PubMed ID: 3918447 [Abstract] [Full Text] [Related]
10. A critical review of the function of neuromelanin and an attempt to provide a unified theory. Nicolaus BJ. Med Hypotheses; 2005 Jan 15; 65(4):791-6. PubMed ID: 15949901 [Abstract] [Full Text] [Related]
11. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes. Dessinioti C, Stratigos AJ, Rigopoulos D, Katsambas AD. Exp Dermatol; 2009 Sep 15; 18(9):741-9. PubMed ID: 19555431 [Abstract] [Full Text] [Related]
15. [Oculocutaneous albinism and tyrosinuria. Description of a clinical case]. Assensio AM, Cascone C, Fracassi A, Parisi SG, Lubrano R, Giardini O. Minerva Pediatr; 1983 Feb 15; 35(3):99-103. PubMed ID: 6843532 [No Abstract] [Full Text] [Related]
16. Genetics of pigmentary disorders. Tomita Y, Suzuki T. Am J Med Genet C Semin Med Genet; 2004 Nov 15; 131C(1):75-81. PubMed ID: 15452859 [Abstract] [Full Text] [Related]
17. The actions of melanin and melanocyte stimulating hormone (MSH). Rasmussen N, Nelson F, Govitrapong P, Ebadi M. Neuro Endocrinol Lett; 1999 Nov 15; 20(5):265-282. PubMed ID: 11460086 [Abstract] [Full Text] [Related]
18. Hypopigmentation in Angelman syndrome. King RA, Wiesner GL, Townsend D, White JG. Am J Med Genet; 1993 Apr 01; 46(1):40-4. PubMed ID: 8494033 [Abstract] [Full Text] [Related]